1 Study Coverage 1.1 Amyotrophic Lateral Sclerosis (ALS) Product Introduction 1.2 Global Amyotrophic Lateral Sclerosis (ALS) Outlook 2017 VS 2022 VS 2028 1.2.1 Global Amyotrophic Lateral Sclerosis (ALS) Sales in US$ Million for the Year 2017-2028 1.2.2 Global Amyotrophic Lateral Sclerosis (ALS) Sales in Volume for the Year 2017-2028 1.3 United States Amyotrophic Lateral Sclerosis (ALS) Outlook 2017 VS 2022 VS 2028 1.3.1 United States Amyotrophic Lateral Sclerosis (ALS) Sales in US$ Million for the Year 2017-2028 1.3.2 United States Amyotrophic Lateral Sclerosis (ALS) Sales in Volume for the Year 2017-2028 1.4 Amyotrophic Lateral Sclerosis (ALS) Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.4.1 The Market Share of United States Amyotrophic Lateral Sclerosis (ALS) in Global, 2017 VS 2022 VS 2028 1.4.2 The Growth Rate of Amyotrophic Lateral Sclerosis (ALS) Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.5 Amyotrophic Lateral Sclerosis (ALS) Market Dynamics 1.5.1 Amyotrophic Lateral Sclerosis (ALS) Industry Trends 1.5.2 Amyotrophic Lateral Sclerosis (ALS) Market Drivers 1.5.3 Amyotrophic Lateral Sclerosis (ALS) Market Challenges 1.5.4 Amyotrophic Lateral Sclerosis (ALS) Market Restraints 1.6 Study Objectives 1.7 Years Considered 2 Market by Type 2.1 Amyotrophic Lateral Sclerosis (ALS) Market Segment by Type 2.1.1 Riluzole 2.1.2 Edaravone (Radicava) 2.1.3 Other 2.2 Global Amyotrophic Lateral Sclerosis (ALS) Market Size by Type 2.2.1 Global Amyotrophic Lateral Sclerosis (ALS) Sales in Value, by Type (2017, 2022 & 2028) 2.2.2 Global Amyotrophic Lateral Sclerosis (ALS) Sales in Volume, by Type (2017, 2022 & 2028) 2.2.3 Global Amyotrophic Lateral Sclerosis (ALS) Average Selling Price (ASP) by Type (2017, 2022 & 2028) 2.3 United States Amyotrophic Lateral Sclerosis (ALS) Market Size by Type 2.3.1 United States Amyotrophic Lateral Sclerosis (ALS) Sales in Value, by Type (2017, 2022 & 2028) 2.3.2 United States Amyotrophic Lateral Sclerosis (ALS) Sales in Volume, by Type (2017, 2022 & 2028) 2.3.3 United States Amyotrophic Lateral Sclerosis (ALS) Average Selling Price (ASP) by Type (2017, 2022 & 2028) 3 Market by Application 3.1 Amyotrophic Lateral Sclerosis (ALS) Market Segment by Application 3.1.1 Hospital 3.1.2 Drugs Store 3.1.3 Other 3.2 Global Amyotrophic Lateral Sclerosis (ALS) Market Size by Application 3.2.1 Global Amyotrophic Lateral Sclerosis (ALS) Sales in Value, by Application (2017, 2022 & 2028) 3.2.2 Global Amyotrophic Lateral Sclerosis (ALS) Sales in Volume, by Application (2017, 2022 & 2028) 3.3.3 Global Amyotrophic Lateral Sclerosis (ALS) Average Selling Price (ASP) by Application (2017, 2022 & 2028) 3.3 United States Amyotrophic Lateral Sclerosis (ALS) Market Size by Application 3.3.1 United States Amyotrophic Lateral Sclerosis (ALS) Sales in Value, by Application (2017, 2022 & 2028) 3.3.2 United States Amyotrophic Lateral Sclerosis (ALS) Sales in Volume, by Application (2017, 2022 & 2028) 3.3.3 United States Amyotrophic Lateral Sclerosis (ALS) Average Selling Price (ASP) by Application (2017, 2022 & 2028) 4 Global Amyotrophic Lateral Sclerosis (ALS) Competitor Landscape by Company 4.1 Global Amyotrophic Lateral Sclerosis (ALS) Market Size by Company 4.1.1 Top Global Amyotrophic Lateral Sclerosis (ALS) Manufacturers Ranked by Revenue (2021) 4.1.2 Global Amyotrophic Lateral Sclerosis (ALS) Revenue by Manufacturer (2017-2022) 4.1.3 Global Amyotrophic Lateral Sclerosis (ALS) Sales by Manufacturer (2017-2022) 4.1.4 Global Amyotrophic Lateral Sclerosis (ALS) Price by Manufacturer (2017-2022) 4.2 Global Amyotrophic Lateral Sclerosis (ALS) Concentration Ratio (CR) 4.2.1 Amyotrophic Lateral Sclerosis (ALS) Market Concentration Ratio (CR) (2017-2022) 4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Amyotrophic Lateral Sclerosis (ALS) in 2021 4.2.3 Global Amyotrophic Lateral Sclerosis (ALS) Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 4.3 Global Amyotrophic Lateral Sclerosis (ALS) Manufacturing Base Distribution, Product Type 4.3.1 Global Amyotrophic Lateral Sclerosis (ALS) Manufacturers, Headquarters and Distribution of Producing Region 4.3.2 Manufacturers Amyotrophic Lateral Sclerosis (ALS) Product Type 4.3.3 Date of International Manufacturers Enter into Amyotrophic Lateral Sclerosis (ALS) Market 4.4 Manufacturers Mergers & Acquisitions, Expansion Plans 4.5 United States Amyotrophic Lateral Sclerosis (ALS) Market Size by Company 4.5.1 Top Amyotrophic Lateral Sclerosis (ALS) Players in United States, Ranked by Revenue (2021) 4.5.2 United States Amyotrophic Lateral Sclerosis (ALS) Revenue by Players (2020, 2021 & 2022) 4.5.3 United States Amyotrophic Lateral Sclerosis (ALS) Sales by Players (2020, 2021 & 2022) 5 Global Amyotrophic Lateral Sclerosis (ALS) Market Size by Region 5.1 Global Amyotrophic Lateral Sclerosis (ALS) Market Size by Region: 2017 VS 2022 VS 2028 5.2 Global Amyotrophic Lateral Sclerosis (ALS) Market Size in Volume by Region (2017-2028) 5.2.1 Global Amyotrophic Lateral Sclerosis (ALS) Sales in Volume by Region: 2017-2022 5.2.2 Global Amyotrophic Lateral Sclerosis (ALS) Sales in Volume Forecast by Region (2023-2028) 5.3 Global Amyotrophic Lateral Sclerosis (ALS) Market Size in Value by Region (2017-2028) 5.3.1 Global Amyotrophic Lateral Sclerosis (ALS) Sales in Value by Region: 2017-2022 5.3.2 Global Amyotrophic Lateral Sclerosis (ALS) Sales in Value by Region: 2023-2028 6 Segment in Region Level & Country Level 6.1 North America 6.1.1 North America Amyotrophic Lateral Sclerosis (ALS) Market Size YoY Growth 2017-2028 6.1.2 North America Amyotrophic Lateral Sclerosis (ALS) Market Facts & Figures by Country (2017, 2022 & 2028) 6.1.3 U.S. 6.1.4 Canada 6.2 Asia-Pacific 6.2.1 Asia-Pacific Amyotrophic Lateral Sclerosis (ALS) Market Size YoY Growth 2017-2028 6.2.2 Asia-Pacific Amyotrophic Lateral Sclerosis (ALS) Market Facts & Figures by Region (2017, 2022 & 2028) 6.2.3 China 6.2.4 Japan 6.2.5 South Korea 6.2.6 India 6.2.7 Australia 6.2.8 Taiwan 6.2.9 Indonesia 6.2.10 Thailand 6.2.11 Malaysia 6.2.12 Philippines 6.3 Europe 6.3.1 Europe Amyotrophic Lateral Sclerosis (ALS) Market Size YoY Growth 2017-2028 6.3.2 Europe Amyotrophic Lateral Sclerosis (ALS) Market Facts & Figures by Country (2017, 2022 & 2028) 6.3.3 Germany 6.3.4 France 6.3.5 U.K. 6.3.6 Italy 6.3.7 Russia 6.4 Latin America 6.4.1 Latin America Amyotrophic Lateral Sclerosis (ALS) Market Size YoY Growth 2017-2028 6.4.2 Latin America Amyotrophic Lateral Sclerosis (ALS) Market Facts & Figures by Country (2017, 2022 & 2028) 6.4.3 Mexico 6.4.4 Brazil 6.4.5 Argentina 6.5 Middle East and Africa 6.5.1 Middle East and Africa Amyotrophic Lateral Sclerosis (ALS) Market Size YoY Growth 2017-2028 6.5.2 Middle East and Africa Amyotrophic Lateral Sclerosis (ALS) Market Facts & Figures by Country (2017, 2022 & 2028) 6.5.3 Turkey 6.5.4 Saudi Arabia 6.5.5 U.A.E 7 Company Profiles 7.1 Mitsubishi Tanabe Pharma 7.1.1 Mitsubishi Tanabe Pharma Corporation Information 7.1.2 Mitsubishi Tanabe Pharma Description and Business Overview 7.1.3 Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis (ALS) Sales, Revenue and Gross Margin (2017-2022) 7.1.4 Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis (ALS) Products Offered 7.1.5 Mitsubishi Tanabe Pharma Recent Development 7.2 Sanofi 7.2.1 Sanofi Corporation Information 7.2.2 Sanofi Description and Business Overview 7.2.3 Sanofi Amyotrophic Lateral Sclerosis (ALS) Sales, Revenue and Gross Margin (2017-2022) 7.2.4 Sanofi Amyotrophic Lateral Sclerosis (ALS) Products Offered 7.2.5 Sanofi Recent Development 7.3 Mylan Pharma 7.3.1 Mylan Pharma Corporation Information 7.3.2 Mylan Pharma Description and Business Overview 7.3.3 Mylan Pharma Amyotrophic Lateral Sclerosis (ALS) Sales, Revenue and Gross Margin (2017-2022) 7.3.4 Mylan Pharma Amyotrophic Lateral Sclerosis (ALS) Products Offered 7.3.5 Mylan Pharma Recent Development 7.4 Apotex 7.4.1 Apotex Corporation Information 7.4.2 Apotex Description and Business Overview 7.4.3 Apotex Amyotrophic Lateral Sclerosis (ALS) Sales, Revenue and Gross Margin (2017-2022) 7.4.4 Apotex Amyotrophic Lateral Sclerosis (ALS) Products Offered 7.4.5 Apotex Recent Development 7.5 Glemark Generics 7.5.1 Glemark Generics Corporation Information 7.5.2 Glemark Generics Description and Business Overview 7.5.3 Glemark Generics Amyotrophic Lateral Sclerosis (ALS) Sales, Revenue and Gross Margin (2017-2022) 7.5.4 Glemark Generics Amyotrophic Lateral Sclerosis (ALS) Products Offered 7.5.5 Glemark Generics Recent Development 7.6 Covis Pharma 7.6.1 Covis Pharma Corporation Information 7.6.2 Covis Pharma Description and Business Overview 7.6.3 Covis Pharma Amyotrophic Lateral Sclerosis (ALS) Sales, Revenue and Gross Margin (2017-2022) 7.6.4 Covis Pharma Amyotrophic Lateral Sclerosis (ALS) Products Offered 7.6.5 Covis Pharma Recent Development 7.7 Sun Pharma 7.7.1 Sun Pharma Corporation Information 7.7.2 Sun Pharma Description and Business Overview 7.7.3 Sun Pharma Amyotrophic Lateral Sclerosis (ALS) Sales, Revenue and Gross Margin (2017-2022) 7.7.4 Sun Pharma Amyotrophic Lateral Sclerosis (ALS) Products Offered 7.7.5 Sun Pharma Recent Development 7.8 Lunan Pharma 7.8.1 Lunan Pharma Corporation Information 7.8.2 Lunan Pharma Description and Business Overview 7.8.3 Lunan Pharma Amyotrophic Lateral Sclerosis (ALS) Sales, Revenue and Gross Margin (2017-2022) 7.8.4 Lunan Pharma Amyotrophic Lateral Sclerosis (ALS) Products Offered 7.8.5 Lunan Pharma Recent Development 8 Industry Chain and Sales Channels Analysis 8.1 Amyotrophic Lateral Sclerosis (ALS) Industry Chain Analysis 8.2 Amyotrophic Lateral Sclerosis (ALS) Key Raw Materials 8.2.1 Key Raw Materials 8.2.2 Amyotrophic Lateral Sclerosis (ALS) Distributors 8.3 Amyotrophic Lateral Sclerosis (ALS) Production Mode & Process 8.4 Amyotrophic Lateral Sclerosis (ALS) Sales and Marketing 8.4.1 Amyotrophic Lateral Sclerosis (ALS) Sales Channels 8.4.2 Amyotrophic Lateral Sclerosis (ALS) Distributors 8.5 Amyotrophic Lateral Sclerosis (ALS) Customers 9 Research Findings and Conclusion 10 Appendix 10.1 Research Methodology 10.1.1 Methodology/Research Approach 10.1.2 Data Source 10.2 Author Details 10.3 Disclaimer

List of Tables Table 1. Amyotrophic Lateral Sclerosis (ALS) CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028 Table 2. Amyotrophic Lateral Sclerosis (ALS) Market Trends Table 3. Amyotrophic Lateral Sclerosis (ALS) Market Drivers Table 4. Amyotrophic Lateral Sclerosis (ALS) Market Challenges Table 5. Amyotrophic Lateral Sclerosis (ALS) Market Restraints Table 6. Global Amyotrophic Lateral Sclerosis (ALS) Sales by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 7. United States Amyotrophic Lateral Sclerosis (ALS) Sales by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 8. Global Amyotrophic Lateral Sclerosis (ALS) Sales by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 9. United States Amyotrophic Lateral Sclerosis (ALS) Sales by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 10. Top Amyotrophic Lateral Sclerosis (ALS) Manufacturers in Global Market, Ranking by Revenue (2021) Table 11. Global Amyotrophic Lateral Sclerosis (ALS) Revenue by Manufacturer, (US$ Million), 2017-2022 Table 12. Global Amyotrophic Lateral Sclerosis (ALS) Revenue Share by Manufacturer, 2017-2022 Table 13. Global Amyotrophic Lateral Sclerosis (ALS) Sales by Manufacturer, (K MT), 2017-2022 Table 14. Global Amyotrophic Lateral Sclerosis (ALS) Sales Share by Manufacturer, 2017-2022 Table 15. Global Amyotrophic Lateral Sclerosis (ALS) Price by Manufacturer (2017-2022) & (USD/MT) Table 16. Global Amyotrophic Lateral Sclerosis (ALS) Manufacturers Market Concentration Ratio (CR5 and HHI) Table 17. Global Amyotrophic Lateral Sclerosis (ALS) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Amyotrophic Lateral Sclerosis (ALS) as of 2021) Table 18. Top Players of Amyotrophic Lateral Sclerosis (ALS) in Global Market, Headquarters and Distribution of Producing Region Table 19. Manufacturers Amyotrophic Lateral Sclerosis (ALS) Product Type Table 20. Date of International Manufacturers Enter into Amyotrophic Lateral Sclerosis (ALS) Market Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans Table 22. Top Amyotrophic Lateral Sclerosis (ALS) Players in United States Market, Ranking by Revenue (2021) Table 23. United States Amyotrophic Lateral Sclerosis (ALS) Revenue by Players, (US$ Million), 2020, 2021 & 2022 Table 24. United States Amyotrophic Lateral Sclerosis (ALS) Revenue Share by Players, 2020, 2021 & 2022 Table 25. United States Amyotrophic Lateral Sclerosis (ALS) Sales by Players, (K MT), 2020, 2021 & 2022 Table 26. United States Amyotrophic Lateral Sclerosis (ALS) Sales Share by Players, 2020, 2021 & 2022 Table 27. Global Amyotrophic Lateral Sclerosis (ALS) Market Size by Region (US$ Million): 2017 VS 2022 VS 2028 Table 28. Global Amyotrophic Lateral Sclerosis (ALS) Sales in Volume by Region (2017-2022) & (K MT) Table 29. Global Amyotrophic Lateral Sclerosis (ALS) Sales in Volume Forecast by Region (2023-2028) & (K MT) Table 30. Global Amyotrophic Lateral Sclerosis (ALS) Sales in Value by Region (2017-2022) & (US$ Million) Table 31. Global Amyotrophic Lateral Sclerosis (ALS) Sales in Value Forecast by Region (2023-2028) & (US$ Million) Table 32. North America Amyotrophic Lateral Sclerosis (ALS) Sales in Volume by Country (2017-2028) & (K MT) Table 33. North America Amyotrophic Lateral Sclerosis (ALS) Sales in Value by Country (2017-2028) & (US$ Million) Table 34. Asia Pacific Amyotrophic Lateral Sclerosis (ALS) Sales in Volume by Region (2017-2028) & (K MT) Table 35. Asia Pacific Amyotrophic Lateral Sclerosis (ALS) Sales in Value by Region (2017-2028) & (US$ Million) Table 36. Europe Amyotrophic Lateral Sclerosis (ALS) Sales in Volume by Country (2017-2028) & (K MT) Table 37. Europe Amyotrophic Lateral Sclerosis (ALS) Sales in Value by Country (2017-2028) & (US$ Million) Table 38. Latin America Amyotrophic Lateral Sclerosis (ALS) Sales in Volume by Country (2017-2028) & (K MT) Table 39. Latin Americaa Amyotrophic Lateral Sclerosis (ALS) Sales in Value by Country (2017-2028) & (US$ Million) Table 40. Middle East and Africa Amyotrophic Lateral Sclerosis (ALS) Sales in Volume by Country (2017-2028) & (K MT) Table 41. Middle East and Africa Amyotrophic Lateral Sclerosis (ALS) Sales in Value by Country (2017-2028) & (US$ Million) Table 42. Mitsubishi Tanabe Pharma Corporation Information Table 43. Mitsubishi Tanabe Pharma Description and Business Overview Table 44. Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis (ALS) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 45. Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis (ALS) Product Table 46. Mitsubishi Tanabe Pharma Recent Development Table 47. Sanofi Corporation Information Table 48. Sanofi Description and Business Overview Table 49. Sanofi Amyotrophic Lateral Sclerosis (ALS) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 50. Sanofi Product Table 51. Sanofi Recent Development Table 52. Mylan Pharma Corporation Information Table 53. Mylan Pharma Description and Business Overview Table 54. Mylan Pharma Amyotrophic Lateral Sclerosis (ALS) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 55. Mylan Pharma Product Table 56. Mylan Pharma Recent Development Table 57. Apotex Corporation Information Table 58. Apotex Description and Business Overview Table 59. Apotex Amyotrophic Lateral Sclerosis (ALS) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 60. Apotex Product Table 61. Apotex Recent Development Table 62. Glemark Generics Corporation Information Table 63. Glemark Generics Description and Business Overview Table 64. Glemark Generics Amyotrophic Lateral Sclerosis (ALS) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 65. Glemark Generics Product Table 66. Glemark Generics Recent Development Table 67. Covis Pharma Corporation Information Table 68. Covis Pharma Description and Business Overview Table 69. Covis Pharma Amyotrophic Lateral Sclerosis (ALS) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 70. Covis Pharma Product Table 71. Covis Pharma Recent Development Table 72. Sun Pharma Corporation Information Table 73. Sun Pharma Description and Business Overview Table 74. Sun Pharma Amyotrophic Lateral Sclerosis (ALS) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 75. Sun Pharma Product Table 76. Sun Pharma Recent Development Table 77. Lunan Pharma Corporation Information Table 78. Lunan Pharma Description and Business Overview Table 79. Lunan Pharma Amyotrophic Lateral Sclerosis (ALS) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 80. Lunan Pharma Product Table 81. Lunan Pharma Recent Development Table 82. Key Raw Materials Lists Table 83. Raw Materials Key Suppliers Lists Table 84. Amyotrophic Lateral Sclerosis (ALS) Customers List Table 85. Amyotrophic Lateral Sclerosis (ALS) Distributors List Table 86. Research Programs/Design for This Report Table 87. Key Data Information from Secondary Sources Table 88. Key Data Information from Primary Sources List of Figures Figure 1. Amyotrophic Lateral Sclerosis (ALS) Product Picture Figure 2. Global Amyotrophic Lateral Sclerosis (ALS) Revenue, (US$ Million), 2017 VS 2022 VS 2028 Figure 3. Global Amyotrophic Lateral Sclerosis (ALS) Market Size 2017-2028 (US$ Million) Figure 4. Global Amyotrophic Lateral Sclerosis (ALS) Sales 2017-2028 (K MT) Figure 5. United States Amyotrophic Lateral Sclerosis (ALS) Revenue, (US$ Million), 2017 VS 2022 VS 2028 Figure 6. United States Amyotrophic Lateral Sclerosis (ALS) Market Size 2017-2028 (US$ Million) Figure 7. United States Amyotrophic Lateral Sclerosis (ALS) Sales 2017-2028 (K MT) Figure 8. United States Amyotrophic Lateral Sclerosis (ALS) Market Share in Global, in Value (US$ Million) 2017-2028 Figure 9. United States Amyotrophic Lateral Sclerosis (ALS) Market Share in Global, in Volume (K MT) 2017-2028 Figure 10. Amyotrophic Lateral Sclerosis (ALS) Report Years Considered Figure 11. Product Picture of Riluzole Figure 12. Product Picture of Edaravone (Radicava) Figure 13. Product Picture of Other Figure 14. Global Amyotrophic Lateral Sclerosis (ALS) Market Share by Type in 2022 & 2028 Figure 15. Global Amyotrophic Lateral Sclerosis (ALS) Sales in Value by Type (2017-2028) & (US$ Million) Figure 16. Global Amyotrophic Lateral Sclerosis (ALS) Sales Market Share in Value by Type (2017-2028) Figure 17. Global Amyotrophic Lateral Sclerosis (ALS) Sales by Type (2017-2028) & (K MT) Figure 18. Global Amyotrophic Lateral Sclerosis (ALS) Sales Market Share in Volume by Type (2017-2028) Figure 19. Global Amyotrophic Lateral Sclerosis (ALS) Price by Type (2017-2028) & (USD/MT) Figure 20. United States Amyotrophic Lateral Sclerosis (ALS) Market Share by Type in 2022 & 2028 Figure 21. United States Amyotrophic Lateral Sclerosis (ALS) Sales in Value by Type (2017-2028) & (US$ Million) Figure 22. United States Amyotrophic Lateral Sclerosis (ALS) Sales Market Share in Value by Type (2017-2028) Figure 23. United States Amyotrophic Lateral Sclerosis (ALS) Sales by Type (2017-2028) & (K MT) Figure 24. United States Amyotrophic Lateral Sclerosis (ALS) Sales Market Share in Volume by Type (2017-2028) Figure 25. United States Amyotrophic Lateral Sclerosis (ALS) Price by Type (2017-2028) & (USD/MT) Figure 26. Product Picture of Hospital Figure 27. Product Picture of Drugs Store Figure 28. Product Picture of Other Figure 29. Global Amyotrophic Lateral Sclerosis (ALS) Market Share by Application in 2022 & 2028 Figure 30. Global Amyotrophic Lateral Sclerosis (ALS) Sales in Value by Application (2017-2028) & (US$ Million) Figure 31. Global Amyotrophic Lateral Sclerosis (ALS) Sales Market Share in Value by Application (2017-2028) Figure 32. Global Amyotrophic Lateral Sclerosis (ALS) Sales by Application (2017-2028) & (K MT) Figure 33. Global Amyotrophic Lateral Sclerosis (ALS) Sales Market Share in Volume by Application (2017-2028) Figure 34. Global Amyotrophic Lateral Sclerosis (ALS) Price by Application (2017-2028) & (USD/MT) Figure 35. United States Amyotrophic Lateral Sclerosis (ALS) Market Share by Application in 2022 & 2028 Figure 36. United States Amyotrophic Lateral Sclerosis (ALS) Sales in Value by Application (2017-2028) & (US$ Million) Figure 37. United States Amyotrophic Lateral Sclerosis (ALS) Sales Market Share in Value by Application (2017-2028) Figure 38. United States Amyotrophic Lateral Sclerosis (ALS) Sales by Application (2017-2028) & (K MT) Figure 39. United States Amyotrophic Lateral Sclerosis (ALS) Sales Market Share in Volume by Application (2017-2028) Figure 40. United States Amyotrophic Lateral Sclerosis (ALS) Price by Application (2017-2028) & (USD/MT) Figure 41. North America Amyotrophic Lateral Sclerosis (ALS) Sales in Volume Growth Rate 2017-2028 (K MT) Figure 42. North America Amyotrophic Lateral Sclerosis (ALS) Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 43. U.S. Amyotrophic Lateral Sclerosis (ALS) Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 44. Canada Amyotrophic Lateral Sclerosis (ALS) Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 45. Europe Amyotrophic Lateral Sclerosis (ALS) Sales in Volume Growth Rate 2017-2028 (K MT) Figure 46. Europe Amyotrophic Lateral Sclerosis (ALS) Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 47. Germany Amyotrophic Lateral Sclerosis (ALS) Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 48. France Amyotrophic Lateral Sclerosis (ALS) Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 49. U.K. Amyotrophic Lateral Sclerosis (ALS) Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 50. Italy Amyotrophic Lateral Sclerosis (ALS) Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 51. Russia Amyotrophic Lateral Sclerosis (ALS) Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 52. Asia-Pacific Amyotrophic Lateral Sclerosis (ALS) Sales in Volume Growth Rate 2017-2028 (K MT) Figure 53. Asia-Pacific Amyotrophic Lateral Sclerosis (ALS) Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 54. China Amyotrophic Lateral Sclerosis (ALS) Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 55. Japan Amyotrophic Lateral Sclerosis (ALS) Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 56. South Korea Amyotrophic Lateral Sclerosis (ALS) Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 57. India Amyotrophic Lateral Sclerosis (ALS) Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 58. Australia Amyotrophic Lateral Sclerosis (ALS) Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 59. Taiwan Amyotrophic Lateral Sclerosis (ALS) Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 60. Indonesia Amyotrophic Lateral Sclerosis (ALS) Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 61. Thailand Amyotrophic Lateral Sclerosis (ALS) Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 62. Malaysia Amyotrophic Lateral Sclerosis (ALS) Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 63. Philippines Amyotrophic Lateral Sclerosis (ALS) Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 64. Latin America Amyotrophic Lateral Sclerosis (ALS) Sales in Volume Growth Rate 2017-2028 (K MT) Figure 65. Latin America Amyotrophic Lateral Sclerosis (ALS) Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 66. Mexico Amyotrophic Lateral Sclerosis (ALS) Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 67. Brazil Amyotrophic Lateral Sclerosis (ALS) Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 68. Argentina Amyotrophic Lateral Sclerosis (ALS) Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 69. Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Sales in Volume Growth Rate 2017-2028 (K MT) Figure 70. Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 71. Turkey Amyotrophic Lateral Sclerosis (ALS) Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 72. Saudi Arabia Amyotrophic Lateral Sclerosis (ALS) Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 73. U.A.E Amyotrophic Lateral Sclerosis (ALS) Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 74. Amyotrophic Lateral Sclerosis (ALS) Value Chain Figure 75. Amyotrophic Lateral Sclerosis (ALS) Production Process Figure 76. Channels of Distribution Figure 77. Distributors Profiles Figure 78. Bottom-up and Top-down Approaches for This Report Figure 79. Data Triangulation Figure 80. Key Executives Interviewed

Mitsubishi Tanabe Pharma Sanofi Mylan Pharma Apotex Glemark Generics Covis Pharma Sun Pharma Lunan Pharma